Digital image analysis improves precision of PD-L1 scoring in cutaneous melanoma-Reference-Cited by-同舟云学术

Digital image analysis improves precision of PD-L1 scoring in cutaneous melanoma

Published:2018-06-05 Issue:3 Volume:73 Page:397-406
ISSN:0309-0167
Container-title:Histopathology
language:en
Short-container-title:Histopathology

Author:

Koelzer Viktor H¹²^ORCID,Gisler Aline¹,Hanhart Jonathan C¹,Griss Johannes³,Wagner Stephan N³,Willi Niels¹,Cathomas Gieri¹,Sachs Melanie¹,Kempf Werner⁴,Thommen Daniela S⁵⁶,Mertz Kirsten D¹

Affiliation:

1. Cantonal Hospital Baselland; Institute of Pathology; Liestal Switzerland

2. Translational Research Unit (TRU); Institute of Pathology; University of Bern; Bern Switzerland

3. Division of Immunology, Allergy and Infectious Diseases (DIAID); Department of Dermatology; Medical University of Vienna; Vienna Austria

4. Kempf und Pfaltz Histologische Diagnostik, Research Unit; Zürich Switzerland

5. Cancer Immunology; Department of Biomedicine; University Hospital Basel; Basel Switzerland

6. Division of Molecular Oncology and Immunology; the Netherlands Cancer Institute; Amsterdam the Netherlands

Funder

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Austrian Science Fund

Edoardo R., Giovanni, Giuseppe and Chiarina Sassella foundation

Krebsliga Beider Basel

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/his.13528/fullpdf

Reference44 articles.

1. PD-1 and PD-l1 checkpoint signaling inhibition for cancer immunotherapy: mechanism, combinations, and clinical outcome;Alsaab;Front. Pharmacol.,2017

2. Immune checkpoint blockade: a common denominator approach to cancer therapy;Topalian;Cancer Cell,2015

3. Immune checkpoint blockade in cancer therapy;Postow;J. Clin. Oncol.,2015

4. Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma;Hamid;N. Engl. J. Med.,2013

5. Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab;Topalian;J. Clin. Oncol.,2014

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting immune checkpoint therapy response in three independent metastatic melanoma cohorts;Frontiers in Oncology;2024-07-02

2. Predicting immune checkpoint therapy response in three independent metastatic melanoma cohorts;2024-05-04

3. Artificial intelligence-based assessment of PD-L1 expression in diffuse large B cell lymphoma;npj Precision Oncology;2024-03-27

4. Correlation Between ImageJ and Conventional Manual Scoring Methods for Programmed Death-Ligand 1 Immuno-Histochemically Stained Sections;Technology in Cancer Research & Treatment;2024-01

5. Evolutionary design of explainable algorithms for biomedical image segmentation;Nature Communications;2023-11-06